The online version of this article (https://doi.org/10.1007/s00192-017-3481-6) contains supplementary material, which is available to authorized users.
Standardized measures enable the comparison of outcomes across providers and treatments giving valuable information for improving care quality and efficacy. The aim of this project was to define a minimum standard set of outcome measures and case-mix factors for evaluating the care of patients with overactive bladder (OAB).
The International Consortium for Health Outcomes Measurement (ICHOM) convened an international working group (WG) of leading clinicians and patients to engage in a structured method for developing a core outcome set. Consensus was determined by a modified Delphi process, and discussions were supported by both literature review and patient input.
The standard set measures outcomes of care for adults seeking treatment for OAB, excluding residents of long-term care facilities. The WG focused on treatment outcomes identified as most important key outcome domains to patients: symptom burden and bother, physical functioning, emotional health, impact of symptoms and treatment on quality of life, and success of treatment. Demographic information and case-mix factors that may affect these outcomes were also included.
The standardized outcome set for evaluating clinical care is appropriate for use by all health providers caring for patients with OAB, regardless of specialty or geographic location, and provides key data for quality improvement activities and research.
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Joint publication: Neurourol Urodyn. 2002;21(2):167–178, Urology. 2003;61:37–49.
Milsom I, Coyne KS, Nicholson S, et al. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79–95. https://doi.org/10.1016/j.eururo.2013.08.031. CrossRefPubMed
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36. PubMed
Porter ME, Lee TH. The strategy that will fix health care. Harvard Bus Rev. 2013;91:50–70.
Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400. https://doi.org/10.1016/j.jclinepi.2010.09.012. CrossRefPubMed
Cleary PD, Meterko M, Wright SM, Zaslavsky AM. Are comparisons of patient experience across hospitals fair? A study in veterans health administration hospitals. Med Care. 2014;52(7):619–25. https://doi.org/10.1161/HYPERTENSIONAHA.113.02854.Impact. CrossRefPubMedPubMedCentral
5 th International Consultation on Incontinence. Editors Abrams, Cardozo, Kouhry and Wein. Health Publications Ltd, Paris 2013.
Colman S, Chapple C, Nitti V, et al. Validation of treatment benefit scale for assessing subjective outcomes in treating overactive bladder. Female Urology. 2008;72(4):803–7. https://doi.org/10.1016/j.urology.2008.05.033. CrossRefPubMed
Sand PK, Miklos J, Ritter H, Appell R. A comparison of extended-release oxybutynin and tolterodine for treating overactive bladder in women. Int Urogynecol J Pelvic Floor Dysfunct. 2004;15(4):243–8. PubMed
Freeman R, Hill S, Millard R, et al. Reduced perception of urgency in treating overactive bladder with extended-release tolterodine. Obstet Gynecol. 2003;102(3):605–11. PubMed
Chui A, Huang M, Wang C, Kuo H. Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus. Int J of Urology. 2012;19(11):995–1001. CrossRef
Bradley CS, Kennedy CM, Nygaard IE. Pelvic floor symptoms and lifestyle factors in older women. J Women's Health. 2005;14:128–36. CrossRef
Parazinni F, Chiaffarino F, Lavezzari M, et al. Risk factors for stress, urge or mixed urinary incontinence in Italy. BJOG. 2003;110:927–33. CrossRef
Tikkanen KA, Auvinen A, Tiitinen A, et al. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1–12. CrossRef
Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. The Cochrane database of systematic reviews. 2012;10:Cd001405.
- Development of a core set of outcome measures for OAB treatment
Elizabeth Ann Gormley
- Springer London
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II